TGCT research hub

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

This study is testing a new drug, emactuzumab, for Tenosynovial Giant Cell Tumor (TGCT) in people who can't have surgery. It's a phase 3 trial, meaning it's in the later stages of testing to see if the drug is effective and safe compared to a placebo.